2. PROTAC MAPK/ERK Pathway GPCR/G Protein
  3. PROTACs Ras
  4. PROTAC SOS1 degrader-1

PROTAC SOS1degrader-1 是一种有效的 PROTAC SOS1 降解剂，DC50 为 98.4 nM。PROTAC SOS1 Degrader-1 在各种 KRAS 突变的癌细胞中显示出抗增殖活性。PROTAC SOS1 Degrader-1 具有抗肿瘤作用，且具有低毒性。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

PROTAC SOS1 degrader-1

PROTAC SOS1 degrader-1 Chemical Structure

CAS No. : 2913185-35-8

1.  客户无需承担相应的运输费用。

2.  同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户。

规格 价格 是否有货
1 mg ￥5500
询问价格 & 货期

* Please select Quantity before adding items.

PROTAC SOS1 degrader-1 的其他形式现货产品:

Customer Review

Other Forms of PROTAC SOS1 degrader-1:

PROTAC SOS1 degrader-1 相关抗体

Top Publications Citing Use of Products

查看 PROTACs 亚型特异性产品:

查看所有亚型
von Hippel-Lindau (VHL) Cereblon MDM2 cIAP1

查看 Ras 亚型特异性产品:

查看所有亚型
K-Ras H-Ras N-Ras Ras

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

PROTAC SOS1 degrader-1 is a potent PROTAC SOS1 degrader with an DC50 of 98.4 nM. PROTAC SOS1 degrader-1 shows antiproliferation activity in cancer cells with various KRAS mutations. PROTAC SOS1 degrader-1 shows antitumor effect with low toxicity[1].

IC50 & Target

DC50: 98.4 nM (SOS1)[1]
细胞效力
(Cellular Effect)
Cell Line Type Value Description References
A549 IC50
0.232 μM
Compound: 9d
Antiproliferative activity against human A549 cells harboring KRAS G12S mutant assessed as cell growth inhibition incubated for 7 days by CellTiter-Glo 3D cell viability assay
Antiproliferative activity against human A549 cells harboring KRAS G12S mutant assessed as cell growth inhibition incubated for 7 days by CellTiter-Glo 3D cell viability assay
[PMID: 35230841]
ASPC1 IC50
0.307 μM
Compound: 9d
Antiproliferative activity against human ASPC1 cells harboring KRAS G12D mutant assessed as cell growth inhibition incubated for 7 days by CellTiter-Glo 3D cell viability assay
Antiproliferative activity against human ASPC1 cells harboring KRAS G12D mutant assessed as cell growth inhibition incubated for 7 days by CellTiter-Glo 3D cell viability assay
[PMID: 35230841]
ASPC1 IC50
72.3 nM
Compound: 9d
Effect of compound on human ASPC1 cells harboring KRAS G12D mutant assessed as inhibition of ERK phosphorylation incubated for 24 hr by Western blot analysis
Effect of compound on human ASPC1 cells harboring KRAS G12D mutant assessed as inhibition of ERK phosphorylation incubated for 24 hr by Western blot analysis
[PMID: 35230841]
MIA PaCa-2 IC50
0.218 μM
Compound: 9d
Antiproliferative activity against human MIA PaCa-2 cells harboring KRAS G12C mutant assessed as cell growth inhibition incubated for 7 days by CellTiter-Glo 3D cell viability assay
Antiproliferative activity against human MIA PaCa-2 cells harboring KRAS G12C mutant assessed as cell growth inhibition incubated for 7 days by CellTiter-Glo 3D cell viability assay
[PMID: 35230841]
NCI-H358 IC50
0.525 μM
Compound: 9d
Antiproliferative activity against human NCI-H358 cells harboring KRAS G12C mutant assessed as growth inhibition incubated for 7 days by CellTiter-Glo 3D cell viability assay
Antiproliferative activity against human NCI-H358 cells harboring KRAS G12C mutant assessed as growth inhibition incubated for 7 days by CellTiter-Glo 3D cell viability assay
[PMID: 35230841]
SK-LU-1 IC50
0.115 μM
Compound: 9d
Antiproliferative activity against human SK-LU-1 cells harboring KRAS G12D mutant assessed as cell growth inhibition incubated for 7 days by CellTiter-Glo 3D cell viability assay
Antiproliferative activity against human SK-LU-1 cells harboring KRAS G12D mutant assessed as cell growth inhibition incubated for 7 days by CellTiter-Glo 3D cell viability assay
[PMID: 35230841]
SW-620 IC50
0.199 μM
Compound: 9d
Antiproliferative activity against human SW620 cells harboring KRAS G12V mutant assessed as cell growth inhibition incubated for 7 days by CellTiter-Glo 3D cell viability assay
Antiproliferative activity against human SW620 cells harboring KRAS G12V mutant assessed as cell growth inhibition incubated for 7 days by CellTiter-Glo 3D cell viability assay
[PMID: 35230841]
体外研究
(In Vitro)

PROTAC SOS1 degrader-1 (compound 9d) (0.1, 1 μM) shows SOSI degradation activity with an SOS1 protein degradation of 56.2 and 92.5% at 0.1 and 1 μM, respectively[1].
PROTAC SOS1 degrader-1 (0-2000 nM; 24 h) exhibits SOS1 degradation activity with an DC50 of 98.4 nM in a dose- and time-dependent manner in NCI-H358 cells[1].
PROTAC SOS1 degrader-1 (0-2500 nM; 24 h) dose-dependently reduced the SOS1 protein level but showed no effect on SOS2 and KRAS up to 2.5 μM in NCI-H358 and AsPc-1 cells[1].
PROTAC SOS1 degrader-1 (0-2000 nM; 24 h) reduces the expression of KRAS-GTP, induced ERK phosphorylation with an IC50value of 72.3 nM, and significantly increases the pERK level after 6-24 h[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

PROTAC SOS1 degrader-1 相关抗体:

Western Blot Analysis[1]

Cell Line: NCI-H358 cells
Concentration: 0-2000 nM
Incubation Time: 0-24 h
Result: Decreased the expression of SOS1 in a dose- and time-dependent manner in NCI-H358 cells.

RT-PCR[1]

Cell Line: NCI-H358 cells
Concentration: 1 µM
Incubation Time: 24, 48, 72 h
Result: Showed no effffect on SOS2 mRNA expression.

Cell Proliferation Assay[1]

Cell Line: NCI-H358, MIA-PaCa2, AsPC-1, SK-LU-1, SW620, A549 cells
Concentration: 0-10000 nM
Incubation Time: 7 days
Result: Showed anti-proliferation activity with an IC50s of 0.525, 0.218, 0.307, 0.115, 0.199, 0.232 µM and DC50s of 0.098, 0.255, 0.119, 0.104, 0.125, 0.022 µM for NCI-H358, MIA-PaCa2, AsPC-1, SK-LU-1, SW620, A549 cells, respectively.
体内研究
(In Vivo)

PROTAC SOS1 degrader-1 (10 mg/kg; i.p.) shows good PK profile with low toxicity[1].
PROTAC SOS1 degrader-1 (0, 10, 20 mg/kg; i.p.; once a day for 3 weeks) shows significant anti-tumor activities in the xenograft mouse model[1].
Pharmacokinetic Parameters of PROTAC SOS1 degrader-1 in BALB/c mice[1].

compound dose (mg/kg) T1/2 (h) Tmax (h) Cmax (ng/mL) AUClast (h*ng/mL) AUCINF (h*ng/mL) MRTINF-obs(h)
9d 10 8.64±0.31 0.250v±0 1221±132 3895±335 4420±363 10.2±0.4
Male BALB/c mice; 10 mg/kg for i.p.[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male BALB/c mice[1]
Dosage: 10 mg/kg (dissolved in solution containing dimethyl sulfoxide, PEG400, and 10% hydroxypropyl-β-cyclodextrin in water (5/5/90, v/v/v))
Administration: I.p.
Result: Showed good PK profile with high exposure (AUC0‑∞ = 4420 h*ng/mL) and maximum concentration (Cmax = 1221 ng/mL) in mouse plasma.
Animal Model: 6-8 weeks, BALB/c mice [1]
Dosage: 0, 10, 20 mg/kg
Administration: I.p.; once a day for a week
Result: Showed low toxicity for mouse.
Animal Model: 6-8 weeks, BALB/c nude mice (NCI-H358 tumor xenografts) [1]
Dosage: 0, 10, 20 mg/kg
Administration: I.p.; once a day for 3 weeks;
Result: Inhibited the tumor growth by 72.5 and 86.1% at 10 and 20 mg/kg, respectively.
Animal Model: 6-8 weeks, BALB/c nude mice (NCI-H358 tumor xenografts)[1]
Dosage: 0, 20, 50 mg/kg
Administration: Intratumoral injection; twice-weekly for 5 weeks
Result: Significantly prevented tumor growth in vivo with a good safety profile.
分子量

1051.79

Formula

C57H76ClFN10O4S
CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
纯度 & 产品资料
参考文献

PROTAC SOS1 degrader-1 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

PROTAC SOS1 degrader-12913185-35-8PROTACsRaslow toxicityanti-tumorNCI-H358 cellsanti-proliferationKRAS-GTPpERKxenografts modelKRAS MutationsInhibitorinhibitorinhibit

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称：

  

* 需求量：

* 客户姓名：

 

* Email：

* 电话：

 

* 公司或机构名称：

   留言给我们：

Bulk Inquiry

Inquiry Information

产品名称：
PROTAC SOS1 degrader-1
目录号：
HY-145737
需求量：

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

   产品名称：

  

* Lot #：

* 客户姓名：

 

* Email：

   电话：

 

* 部门：

* 公司或机构名称：

 

   留言给我们：

Request for HNMR Report

We have received your request and will respond to you as soon as possible.

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z